期刊文献+

EpCAM和Ki-67在三阴性乳腺癌原发灶及淋巴结转移灶中的表达及临床意义 被引量:2

Expressions of EpCAM and Ki-67 in primary lesion and metastatic lymph nodes of triple-negative breast cancer and their clinical significance
下载PDF
导出
摘要 目的探讨上皮细胞黏附分子(EpCAM)和Ki-67在三阴性乳腺癌(TNBC)原发灶和淋巴结转移灶中的表达及临床意义。方法用免疫组化染色检测81例TNBC原发灶、43例淋巴结转移灶及20例癌旁正常乳腺组织中EpCAM和Ki-67的表达情况。结果 EpCAM和Ki-67在TNBC组织中的过表达率分别为74.1%和61.7%,均高于癌旁正常乳腺组织,差异有统计学意义(P<0.05);EpCAM蛋白表达与TNBC的组织学分级、淋巴结转移有关(P<0.05);Ki-67蛋白表达与组织学分级、淋巴结转移及pTNM分期有关(P<0.05);TNBC组织中EpCAM和Ki-67蛋白表达呈正相关(r=0.462,P<0.001)。在43例伴有淋巴结转移的TNBC患者中,淋巴结转移灶和原发灶中EpCAM和Ki-67蛋白均呈高表达,Ki-67在淋巴结转移灶中的表达率高于原发灶(P<0.05)。结论 EpCAM和Ki-67在TNBC原发灶及淋巴结转移灶中均高表达;EpCAM和Ki-67过表达可能与TNBC的发生、发展密切相关。 Objective To investigate the expressions of epithelial cell adhesion mole-cule(EpCAM) and Ki-67 in primary le- sion and metastatic lymph nodes of triple-negetive breast cancer(TNBC) and their clinical significance. Methods The expressions of EpCAM and Ki-67 were examined by SP immunohistochemical stain(IHC) in 81 cases of TNBC, 43 cases of metastatic lymph nodes and 20 cases of normal breast tissues. Results The overexpression rates of EpCAM and Ki-67 were 74. 1% and 61.7%, respectively. Moreover, the overexpression of EpCAM and Ki-67 in TNBC was significantly higher than that in normal breast tissues( P〈0. 05). The overexpression of EpCAM was correlated with differentiation grade and lymph node metastasis of TNBC (P〈0.05). On the other hand, the high expression of Ki-67 was correlated with differentiation grade, lymph node metastasis and pTNM staging of TNBC (P〈0.05). The overexpression of EpCAM in metastatic lymph nodes was as high as in primary lesion of TNBC, but the high expression of Ki-67 in lymph node metastasis was higher than that in primary lesion(P〈0. 05). Conclusion EpCAM and Ki-67 are expressed highly both in in primary lesion and metastatic lymph nodes of TNBC. The overexpression of EpCAM and Ki-67 can be closely related with the carcinogenesis and progression of TNBC.
出处 《临床肿瘤学杂志》 CAS 2014年第9期795-798,共4页 Chinese Clinical Oncology
基金 河北省卫生厅基金资助项目(20130333)
关键词 三阴性乳腺癌 上皮细胞黏附分子(EpCAM) KI-67 免疫组织化学 淋巴结转移 Triple-negative breast cancer(TNBC) Epithelial cell adhesion mole-cule(EpCAM) Ki-67 Immunohis-tochemieal stain Lymph node metastasis
  • 相关文献

参考文献12

  • 1石永国,卞卫和,何烨,丁洁,周晶,王科明.miR-206对三阴性乳腺癌细胞的增殖抑制作用及初步机制研究[J].临床肿瘤学杂志,2013,18(12):1062-1065. 被引量:3
  • 2Collins LC, Martyniak A, Kandel M J, et al. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast canc- ers[J].Am J Surg Pathol, 2009, 33(7) : 1093-1097.
  • 3沈松杰,孙强,周易冬,关竞红,茅枫,林燕,彭理,徐颖,王雪霏,夏雯,姚儒,韩少梅.三阴性乳腺癌预后相关因素分析[J].中华外科杂志,2013,51(11):1000-1004. 被引量:16
  • 4曹华,闫茂生,郑涛,许瑞莲,陈亦欣,王树滨,刘雅洁.132例三阴性乳腺癌患者的临床特征与预后分析[J].实用肿瘤学杂志,2009,23(2):101-105. 被引量:8
  • 5Mtinz M, Kieu C, Mack B, et al. The carcinoma-associated anti- gen EpCAM upregulates c-myc and induces cell proliferation[ J]. Oncogene, 2004, 23(34): 5748-5758.
  • 6Chelius D, Ruf P, Gruber P, et al. Structural and functional characterization of the trifunctional antibody eatumaxomab [ J ]. MABs, 2010, 2(3) : 309-319.
  • 7Abd EI-Maqsound NM, Abd EI-Rehim DM. Clinicopathologie implications of EpCAM and Sox2 expression in breast cancer[ J]. Clin Breast Cancer, 2014, 14(1) : 1-9.
  • 8周庆华,吴迎,蔡中瑞,朱建新.新辅助化疗对乳腺癌患者ER、PR、C-erbB-2、Ki-67表达的影响[J].中国癌症杂志,2008,18(2):139-141. 被引量:19
  • 9Ni J, Cozzi P, Hao J, et al. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway[ J]. Int J Biochem Cell Biol, 2013, 45 (12) : 2736 -2748.
  • 10Ciminno A, Halushka M, Illei P, et al. Epithelial cell adhesion molecule(EpCAM) is overexpressed in breast cancer metastases [J]. Breast Cancer Res Treat, 2010, 123(3) : 701-708.

二级参考文献52

  • 1毛杰,海健,舒衡平,唐利立,申正堂,邬玉辉,欧慧英.乳腺癌组织中survivin、c-erbB-2基因的表达与预后的关系[J].中国癌症杂志,2005,15(5):432-434. 被引量:8
  • 2费伯健,周士福,金留根,林奇.新辅助化疗对乳腺癌激素受体表达和状态的影响[J].南京医科大学学报(自然科学版),2005,25(11):772-774. 被引量:18
  • 3中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2007版)[J].中国癌症杂志,2007,17(5):410-428. 被引量:230
  • 4Raha EA, Elsayed ME, Green AR, et al. Prognostic markers in triple - negative breast cancer [ J]. Cancer, 2007, 109 (1) :25 -32.
  • 5Morris GJ,Naidu S,Topham AK,et al. Differences in breast carcinoma characteristics in newly diagnosed African - American and Caucasian patients : A single - institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database [ J ]. Cancer,2007,110(4) :876 - 884.
  • 6Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets [ J]. PNAS ,2003,100:8418 - 8423.
  • 7Reis - Filho JS, Tutt AN. Triple negative breast cancer: a critical review [ J ]. Histopathology, 2008,52 ( 1 ) : 108 - 118.
  • 8Kim M J, Ro JY, Ahn SH, et al. Clinicopathologicsignificance of the basal - like subtype of breast cancer: A comparison with hormone receptor and Her- 2/neu- overexpressing phenotypes [ J ]. Hum Pathol,2006,37 (9) : 1217 - 1226.
  • 9Sara M, Bando Y, Takahashi N, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy for triple - negative breast cancer [ J ]. J Surg Oncol,2008,97( 1 ) :30 -34.
  • 10Dent R, Trudeau M, Pritchard KJ, et al. Triple negative breast cancer: clinical features and patterns of recurrence [ J]. Clin Cancer Res ,2007,13:4429 - 4434.

共引文献41

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部